Prospective Adjuvant Therapy Trial Design Using A Prognostic 40-Gene Expression Profile (40-Gep) Test For High-Risk Cutaneous Squamous Cell Carcinoma (Cscc) And Bwh Staging-Based Risk Assessment

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY(2021)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要